Skip to main content
. 2015 Sep 3;6(30):30287–30294. doi: 10.18632/oncotarget.4711

Table 2. KRAS and EGFR mutation status.

N Percent
KRAS MT 38 41%
 Codon 12 35
 Codon 13 2
EGFR MT 5 5%
KRAS WT and EGFR WT 49 53%